Investors Scrutinize Four Corporate Mergers for Potential Misconduct

The legal scrutiny focuses on whether these acquisition terms unfairly restrict competing offers or provide disproportionate benefits to insiders. Arcosa’s sale to CRH at $150.00 per share, Simulations Plus’s deal with Altaris for $18.50 per share, and AstroNova’s cash acquisition by Arcline Investment Management for $29.00 per share are all under review. Additionally, the firm is examining the stock-for-stock agreement between Fathom Holdings and Bed Bath & Beyond, which involves an exchange ratio of 0.2236 shares per Fathom unit.

Halper Sadeh LLC attorneys are seeking to determine if these deals provide adequate compensation and transparent disclosures to investors. The firm indicates it may pursue litigation to secure increased financial consideration or improved terms for shareholders. Affected investors are invited to review their legal options as the firm evaluates whether these corporate actions align with established fiduciary obligations.